investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Optimization of Notch Inhibitors for Treatment of Cancer and Tumour Angiogensis
Aleksandra Filipovic
1 Collaborator(s)
Funding source
Union for International Cancer Control
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Jan Kitajewski
Columbia University
New York, United States
Aleksandra Filipovic
Imperial College London
London, United Kingdom
Related projects
Ken Chen
Delineating Heterogeneous Structural Complexity in Cancer Genomes
All cancers but non-melanoma skin cancer
Alain Charest
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Network
All cancers but non-melanoma skin cancer
Pathology
Leonard Neckers
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
All cancers but non-melanoma skin cancer
Ettore Appella
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
All cancers but non-melanoma skin cancer
Hisataka Kobayashi
Activatable Molecular Cancer Imaging Probe
All cancers but non-melanoma skin cancer
Garrick L Wallstrom
Power analysis tools for biomarker discovery with heterogeneous diseases
All cancers but non-melanoma skin cancer
Caroline Springer
Late Stage Lead Optimisation, Preclinical Development and Clinical Trial of Lysyl Oxidase (LOX) Inhibitors
All cancers but non-melanoma skin cancer
William Joseph Valente
Mitochondrial Mutagenesis and Dysfunction in Cancer Metabolism
All cancers but non-melanoma skin cancer
Todd R. Golub
PQB-3: Discovery and validation of the driving mediators of cancer cachexia
All cancers but non-melanoma skin cancer